{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:22:46Z","timestamp":1773523366949,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,27]]},"DOI":"10.7759\/cureus.100226","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:10:48Z","timestamp":1766905848000},"source":"Crossref","is-referenced-by-count":1,"title":["Neoadjuvant Chemotherapy-Induced Downstaging Enables R0 Craniofacial Combined Resection in AJCC (American Joint Committee on Cancer) Stage IV Olfactory Neuroblastoma: A Case Report of 12-Year Disease-Free Survival"],"prefix":"10.7759","author":[{"given":"Akira","family":"Nakazono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Olfactory neuroepithelioma (Article in French)","volume":"13","author":"Berger L","year":"1924","unstructured":"Berger L, Luc R, Richard D. Olfactory neuroepithelioma (Article in French). Bull Assoc Fr Etude Cancer. 1924, 13:410-21.","journal-title":"Bull Assoc Fr Etude Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.09.010","article-title":"The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival","volume":"74","author":"Turri-Zanoni M","year":"2017","unstructured":"Turri-Zanoni M, Maragliano R, Battaglia P, et al.. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 2017, 74:21-9. 10.1016\/j.oraloncology.2017.09.010","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215116009592","article-title":"Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance","volume":"131","author":"Schmidt C","year":"2017","unstructured":"Schmidt C, Potter N, Porceddu S, Panizza B. Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance. J Laryngol Otol. 2017, 131:S29-34. 10.1017\/S0022215116009592","journal-title":"J Laryngol Otol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(01)00558-7","article-title":"Esthesioneuroblastoma: a meta-analysis and review","volume":"2","author":"Dulguerov P","year":"2001","unstructured":"Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001, 2:683-90. 10.1016\/s1470-2045(01)00558-7","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29732","article-title":"Long-term outcomes of olfactory neuroblastoma: MD Anderson cancer center experience and review of the literature","volume":"132","author":"Abdelmeguid AS","year":"2022","unstructured":"Abdelmeguid AS, Bell D, Roberts D, et al.. Long-term outcomes of olfactory neuroblastoma: MD Anderson cancer center experience and review of the literature. Laryngoscope. 2022, 132:290-7. 10.1002\/lary.29732","journal-title":"Laryngoscope"},{"key":"ref6","article-title":"Olfactory neuroblastoma","author":"Hyams VJ","year":"1988","unstructured":"Hyams VJ, Batsakis JG, Michaels L. Olfactory neuroblastoma. Tumors of the upper respiratory tract and ear. William HH (ed): Armed Forces Institute of Pathology, Washington, D.C.; 1988. 240-8."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199305000-00002","article-title":"Esthesioneuroblastoma: prognosis and management","volume":"32","author":"Morita A","year":"1993","unstructured":"Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993, 32:706-14; discussion 714-5. 10.1227\/00006123-199305000-00002","journal-title":"Neurosurgery"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199208000-00001","article-title":"Esthesioneuroblastoma: the UCLA experience 1970-1990","volume":"102","author":"Dulguerov P","year":"1992","unstructured":"Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992, 102:843-9. 10.1288\/00005537-199208000-00001","journal-title":"Laryngoscope"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref10","unstructured":"CTEP trial development and conduct. (2025). Accessed. December 7, 2025: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm.."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1945892420973163","article-title":"Surgery as single-modality treatment for early-stage olfactory neuroblastoma: an institutional experience, systematic review and meta-analysis","volume":"35","author":"Meerwein CM","year":"2021","unstructured":"Meerwein CM, Nikolaou G, H A Binz G, Soyka MB, Holzmann D. Surgery as single-modality treatment for early-stage olfactory neuroblastoma: an institutional experience, systematic review and meta-analysis. Am J Rhinol Allergy. 2021, 35:525-34. 10.1177\/1945892420973163","journal-title":"Am J Rhinol Allergy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24822","article-title":"Outcomes for olfactory neuroblastoma treated with induction chemotherapy","volume":"39","author":"Su SY","year":"2017","unstructured":"Su SY, Bell D, Ferrarotto R, et al.. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017, 39:1671-9. 10.1002\/hed.24822","journal-title":"Head Neck"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Porter AB","year":"2008","unstructured":"Porter AB, Bernold DM, Giannini C, et al.. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008, 90:201-4. 10.1007\/s11060-008-9645-y","journal-title":"J Neurooncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104618","article-title":"Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma","volume":"103","author":"Song X","year":"2020","unstructured":"Song X, Wang J, Wang S, Yan L, Li Y. Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma. Oral Oncol. 2020, 103:104618. 10.1016\/j.oraloncology.2020.104618","journal-title":"Oral Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25558","article-title":"Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma","volume":"41","author":"Miller KC","year":"2019","unstructured":"Miller KC, Marinelli JP, Van Gompel JJ, et al.. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck. 2019, 41:1335-41. 10.1002\/hed.25558","journal-title":"Head Neck"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.799405","article-title":"Olfactory neuroblastoma: surgical treatment experience of 42 cases","volume":"8","author":"Cai X","year":"2021","unstructured":"Cai X, Peng Z, Zhang H, Fan R, Fang Y, Xie Z. Olfactory neuroblastoma: surgical treatment experience of 42 cases. Front Surg. 2021, 8:799405. 10.3389\/fsurg.2021.799405","journal-title":"Front Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000649","article-title":"Chemotherapy in esthesioneuroblastoma\/olfactory neuroblastoma: an analysis of the surveillance epidemiology and end results (SEER) 1973-2015 database","volume":"43","author":"Cranmer LD","year":"2020","unstructured":"Cranmer LD, Chau B, Rockhill JK, Ferreira M Jr, Liao JJ. Chemotherapy in esthesioneuroblastoma\/olfactory neuroblastoma: an analysis of the surveillance epidemiology and end results (SEER) 1973-2015 database. Am J Clin Oncol. 2020, 43:203-9. 10.1097\/COC.0000000000000649","journal-title":"Am J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20648","article-title":"Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma","volume":"101","author":"Kim DW","year":"2004","unstructured":"Kim DW, Jo YH, Kim JH, et al.. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer. 2004, 101:2257-60. 10.1002\/cncr.20648","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90457-7","article-title":"Esthesioneuroblastoma: the role of adjuvant radiation therapy","volume":"27","author":"Foote RL","year":"1993","unstructured":"Foote RL, Morita A, Ebersold MJ, et al.. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993, 27:835-42. 10.1016\/0360-3016(93)90457-7","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446323-neoadjuvant-chemotherapy-induced-downstaging-enables-r0-craniofacial-combined-resection-in-ajcc-american-joint-committee-on-cancer-stage-iv-olfactory-neuroblastoma-a-case-report-of-12-year-disease-free-survival","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:10:49Z","timestamp":1766905849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446323-neoadjuvant-chemotherapy-induced-downstaging-enables-r0-craniofacial-combined-resection-in-ajcc-american-joint-committee-on-cancer-stage-iv-olfactory-neuroblastoma-a-case-report-of-12-year-disease-free-survival"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100226","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}